Medications

Study: Cancer drugs might be able to target tuberculosis

An unexpected link between tuberculosis and cancer may lead to new drug treatments for the bacterial disease that kills more than 1.5 million people each year, according to a study led by researchers at Stanford Medicine.

Medications

Overcoming resistance to breast cancer treatment

Many breast cancer patients develop resistance to standard drug treatments aimed at preventing the growth of cancer cells. A team from the University of Geneva (UNIGE) has identified a molecular regulator involved in these ...

Oncology & Cancer

Consumer Health: Cancer myths vs. facts

February is National Cancer Prevention Month, which makes this a good time to learn about what does—and does not—cause cancer.

Oncology & Cancer

Research reveals why more Black women die from breast cancer

New research from Sanford Burnham Prebys has revealed significant molecular differences between the breast cells of white and Black women that help explain why Black women experience higher breast cancer mortality. The findings, ...

Oncology & Cancer

Chemotherapy with a reduction of negative consequences

Cancer metastases, the main cause of cancer-related mortality, are sometimes triggered by successful chemotherapy. A research group at the Rappaport Faculty of Medicine analyzed this phenomenon and demonstrated ways of intervening ...

Oncology & Cancer

New path to treat advanced triple-negative breast cancer

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...

Medical research

Novel biomarkers help decode metastatic breast cancer

Breast cancer is the most common cancer in women worldwide, yet despite medical advances, a cure for the tumors that spread locally and especially to the distant sites remains out of reach.

page 34 from 40